APPLICATION
ANDA204339
TYPE
ANDA
ORIGINAL APPROVAL
2013-07-01
LATEST ACTION
2019-11-29
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
RIZATRIPTAN BENZOATEDiscontinued
RIZATRIPTAN BENZOATE EQ 5MG BASE · TABLET · ORAL
RIZATRIPTAN BENZOATEDiscontinued
RIZATRIPTAN BENZOATE EQ 10MG BASE · TABLET · ORAL
Approval history
2019-11-29Labeling · Supplement 9 · standardAP
2019-11-29Labeling · Supplement 3 · standardAP
2015-04-08Labeling · Supplement 2 · standardAP
2013-07-01UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.